Videos

Selected Videos:

• SNMMIChannel – Best Article of the Month (Feb. 2018)
  PSMA PET/CT Visualizes Prostate Cancer Recurrence Early, Impacts Radiation Therapy
• SNMMIChannel – Best Clinical Investigation of the Month (Nov. 2018)
  Prostate Cancer Radiotherapy More Precisely Targeted with Nuclear Medicine Imaging
• Urotoday - PCF Carlsbad 2018
  Effectiveness and Resistance to PSMA Targeted RadioLigand Therapy using 177 Lu-PSMA-617 
• VJOncology – ASCO GU San Francisco 2019
  Gallium-labelled PSMA-11 PET/CT and it’s benefits
  Fluorine-18 FACBC vs. Gallium-labelled PSMA-11 PET/CT for prostate cancer screening
  Prostate cancer radiotherapy planning with Gallium-labelled PSMA-11 PET/CT imaging
• Targeted Oncology – AUA Chicago 2019
  Analyzing Responses to 177LuPSMA-617 in Patients With Metastatic CRPC
• VJOncology – ASCO Chicago 2019
  PSMA vs AXUMIN PET/CT in prostate cancer
  Molecular imaging for prostate cancer salvage radiotherapy planning
  Challenges with novel molecular imaging techniques for prostate cancer
• SAR -  Prostate Disease Focused Panel Podcast 
  Hot of the Press: PSMA vs Fluciclovine PET/CT for Detection of Prostate Cancer Recurrence
• SNMMIChannel – Best Clinical Investigation of the Month (Sep. 2019)
  PET Offers More Precise Screening Method to Select Candidates for Neuroendocrine Tumor Therapy
• VJOncology – ASCO GU San Francisco 2020
  The significant impact of PSMA-PET on prostate cancer staging and management
• eCancer – ASCO GU San Francisco 2020
  Prostate-specific membrane antigen PET: Who should undergo advanced imaging?
• Urotoday – ASCO GU San Francisco 2020
  PSMA PET Diagnostic Imaging in the Current Era

• VuMedi – ASCO 2020
  2020 ASCO Update on mCRPC: What Is the OS After 177Lu-PSMA-617 Molecular Radiotherapy?

• VuMedi – UCLA Health
  Prostate Cancer PET Imaging Biological Target: FACBC vs PSMA PET/CT - Which Option Should Be the Imaging Modality of Choice in Patients With post-RP early BCR? What Is the Best PET Target for Early Biochemical Recurrence of Prostate Cancer?

• VuMedi – UCLA Health 
  PSMA PET/CT Imaging in Prostate Cancer: GALLIUM-68 vs FLUOR-18 PSMA-PET - Which Option Matters for Detection/Localization of Disease? What Is the Impact on Drug Indication?

• VuMedi – UCLA Health 
  PSMA PET Imaging for Primary Staging: Efficacy Analysis of Methods for Ruling-out N1 and M1b Disease?